MGB-BP-3

DB12892InvestigationalSmall molecule

Mgb Bp 3 is under investigation in clinical trial NCT02518607 (Safety, Blood Levels and Effects of MGB-BP-3).

Chemical structure of MGB-BP-3
Formula / weight
C36H37N7O4 · 631.737 g/mol (avg)
Code names
J2.725.402K

Resolves to

Compound
UNII532PWU9738CAS1000277-08-6ChEMBLCHEMBL236345PubChem23730143
Structure
InChIKeyOEKXCVYZBVOWBR-BQYQJAHWSA-NSMILESCN1C=C(NC(=O)C2=CC(NC(=O)C3=CC=C(\C=C\C4=CN=C5C=CC=CC5=C4)C=C3)=CN2C)C=C1C(=O)NCCN1CCOCC1

What you can answer from here — as of April 23, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of MGB-BP-3, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In